These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9330654)

  • 21. P2Y receptor antagonists in thrombosis.
    Boeynaems JM; van Giezen H; Savi P; Herbert JM
    Curr Opin Investig Drugs; 2005 Mar; 6(3):275-82. PubMed ID: 15816504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological effects on thrombocyte aggregation. A review].
    Jøorgensen KA; Dyerberg J
    Ugeskr Laeger; 1980 Mar; 142(12):743-7. PubMed ID: 6989071
    [No Abstract]   [Full Text] [Related]  

  • 23. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes of platelet aggregation in cancer patients].
    Shilova AN; Kotovshchikova EF; Lazarev AF; Barkagan ZS; Buevich EI
    Vopr Onkol; 2007; 53(6):722-3. PubMed ID: 18416146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New roles for antiplatelet agents in treatment of atherothrombotic diseases.
    Bottorff MB
    J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S4. PubMed ID: 15095930
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection.
    Modica A; Karlsson F; Mooe T
    J Thromb Haemost; 2007 Mar; 5(3):507-11. PubMed ID: 17319905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis.
    Yeh ET; Khan BV
    J Thromb Haemost; 2006 Nov; 4(11):2308-16. PubMed ID: 16961584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 30. [Platelet anti-aggregants, from the concept to clinical results].
    Tobelem G
    Rev Prat; 1988 Dec; 38(30):2268-71. PubMed ID: 3222655
    [No Abstract]   [Full Text] [Related]  

  • 31. [Platelet function inhibitors as a way of arterial thrombosis prevention in the diabetic].
    Lecompte T
    Journ Annu Diabetol Hotel Dieu; 2001; ():197-220. PubMed ID: 11565463
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioactive lipids and atherothrombosis.
    FitzGerald GA
    Haematologica; 2001 Nov; 86(11 Suppl 2):3-7. PubMed ID: 11926771
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
    Kamphuisen PW
    Eur Heart J; 2008 Jul; 29(14):1699-700. PubMed ID: 18544543
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibition of thrombocyte aggregation as a therapeutic principle. Review of the literature and currently approved thrombocyte aggregation inhibitors].
    Huber K; Andreesen R
    Internist (Berl); 2000 Apr; 41 Suppl 1():S34-9. PubMed ID: 10840662
    [No Abstract]   [Full Text] [Related]  

  • 35. A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
    Pecot CV; Fuller M; Muldowney JA; Misra S
    Tenn Med; 2009 May; 102(5):37-9. PubMed ID: 19456028
    [No Abstract]   [Full Text] [Related]  

  • 36. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function testing in cardiovascular diseases.
    Michelson AD
    Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
    Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
    Lassila R
    Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dual antiplatelet treatment].
    Krupicka J
    Vnitr Lek; 2008 Oct; 54(10):985-91. PubMed ID: 19009766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.